Sadler R, Singh V, Benakis C, Garzetti D, Brea D, Stecher B, Anrather J, Liesz A.
2017.
Microbiota differences between commercial breeders impacts the post-stroke immune response.. Brain Behav Immun. 66:23-30.
Pineda A, Burré J.
2017.
Modulating membrane binding of α-synuclein as a therapeutic strategy.. Proc Natl Acad Sci U S A. 114(6):1223-1225.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..
2017.
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..
2017.
Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.